Doppler Image

Marketplace Links

Social Links

Main Menu

WRALTechWire 30
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
United Therapeutics Corp (NQ: UTHR)
67.61 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about United Therapeutics Corp
 
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio
Today 4:04 EDT
Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of PEG ratio. United Therapeutics (NASDAQ: UTHR ) has a PEG ratio of 0.28. United Therapeutics had $670.64... Read More
category Benzinga , Drug Manufacturers/Other Industry , UTHR , and 6 more.
from Latest Articles from Benzinga.com
United Therapeutics Has Returned 35.1% Since SmarTrend Recommendation (UTHR)
May 22, 2013
from Comtex SmarTrend® News Briefs
Pre-Market Analysis on STSI, IPXL, PCYC, and UTHR
May 21, 2013
from ACCESSWIRE
Standpoint Research Downgrades United Therapeutics Corp. (UTHR) to Hold
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8341505 for the full story. Read More
from StreetInsider.com News Articles
28.8% Return Seen to Date on SmarTrend United Therapeutics Call (UTHR)
May 06, 2013
from Comtex SmarTrend® News Briefs
Charting the Nasdaq’s 12-year breakout
April 30, 2013
The U.S. markets’ technical backdrop remains firmly bullish. Read More
category Market News , VRX , Opinion , and 10 more.
from MarketWatch
United Therapeutics Has Returned 23.0% Since SmarTrend Recommendation (UTHR)
April 29, 2013
from Comtex SmarTrend® News Briefs
Ladenburg Thalmann Downgrades United Therapeutics Corp. (UTHR) to Neutral
April 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8281714 for the full story. Read More
from StreetInsider.com News Articles
April Showers
April 25, 2013
April has brought a mixed bag of news for Roadrunner stocks, with fears of an economic slowdown hurting share prices in the energy and technology sectors. Read More
from Update Content Feed for Financial Content
United Therapeutics (UTHR) Posts Q1 EPS of $1.24
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8277927 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 04/25: Exxon, (XOM), Dow (DOW), 3M (MMM), Hershey (HSY), UPS (UPS), Expedia (EXPE) Report
April 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8276525 for the full story. Read More
from StreetInsider.com News Articles
Biotechs Near Highs In A Week Of Key Earnings Reports
April 24, 2013
The medical sector has been one of the strongest of the year so far, and biotechs in particular are near highs amid several earnings reports this week. Biotech, health care and pharmaceuticals are the... Read More
category Stocks In The News
from Investor's Business Daily - Investing RSS
Wednesday's ETF with Unusual Volume: BBH
April 24, 2013
The Biotech ETF (BBH) is seeing unusually high volume in afternoon trading Wednesday, with over 225,000 shares traded versus three month average volume of about 73,000. Shares of BBH were off about 3%... Read More
category ETFs
from ETF Channel
Earnings Report Looms For United Therapeutics
April 22, 2013
Shares of United Therapeutics (UTHR) are finding support at the 50-day moving average as the company's earnings announcement looms. The stock has touched the 50-day line the past three sessions and... Read More
category Stocks In The News
from Investor's Business Daily - Investing RSS
Bull’s Eye Report: United Therapeutics Group (UTHR)
April 22, 2013
 Read More
category NASDAQ:UTHR , NYSEARCA:XLV , NYSEARCA:XBI
from InvestorPlace - Latest Headlines
Bearish Moving Average Cross by United Therapeutics (UTHR)
April 17, 2013
from Comtex SmarTrend® News Briefs
United Therapeutics Up 20.2% Since SmarTrend Uptrend Call (UTHR)
April 12, 2013
from Comtex SmarTrend® News Briefs
United Therapeutics Holds 10-Week Despite FDA Setback
April 08, 2013
Medical-sector stocks continue to be well represented in Stock Spotlight. The daily screen does a good job highlighting stocks holding up well in up-and-down markets and provides a place to look for... Read More
category Stocks In The News
from Investor's Business Daily - Investing RSS
16.6% Return Seen to Date on SmarTrend United Therapeutics Call (UTHR)
April 05, 2013
from Comtex SmarTrend® News Briefs
Grab These Short Squeeze Opportunities Before It’s Too Late
March 28, 2013
 Read More
category NASDAQ:INTU , NASDAQ:UTHR , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
13 Drugs Pending FDA Approval in 2013
March 26, 2013
As we cross into spring, the Food & Drug Administration (FDA) will make several announcements regarding the commercial viability of numerous new drugs. Benzinga found days of reckoning for 13 drugs in... Read More
category Benzinga , RPTP , UTHR , and 13 more.
from Latest Articles from Benzinga.com
United Therapeutics Shows Why Buying Early Is Risky
March 25, 2013
Buying before a stock crosses a valid buy point isn't a good idea. Just because a stock sketches a bullish pattern in the stock market today doesn't mean your looking at tomorrow's winner. Successful... Read More
category Stocks In The News
from Investor's Business Daily - Investing RSS
United Therapeutics Corp Moves Up In Market Cap Rank, Passing United States Steel Corp.
March 25, 2013
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component United Therapeutics Corp (UTHR) was identified as having a larger market cap than the smaller end of the... Read More
category Stocks
from Market News Video
Once Again FDA Rejects Oral Treprostinil For Pulmonary Arterial Hypertension
March 25, 2013
For the second time the FDA has issued a complete response letter rejecting the new drug application (NDA) of oral treprostinil for the treatment of pulmonary arterial hypertension (PAH) . The... Read More
category NASDAQ:UTHR
from Forbes Real Time
US STOCKS-Wall St slips, but off lows after Cyprus clarification
March 25, 2013
* Stocks wipe out gains after initial optimism over Cyprus bailout Read More
category companyNews
from Reuters: Company News
US STOCKS-Wall Street falls on renewed European debt worries
March 25, 2013
* Top official says Cyprus deal is template for euro zone fixes Read More
category companyNews
from Reuters: Company News
US STOCKS-Wall St falls after Cyprus deal called model solution
March 25, 2013
* Top official says Cyprus is new template for euro zone fixes Read More
category companyNews
from Reuters: Company News
United Therapeutics (UTHR) falls on thumbs-down by FDA
March 25, 2013
United Therapeutics (NASDAQ: UTHR) dipped 1.7% to $59.94, after the FDA declined to approve its oral drug to treat hypertension. Share volume was 1.1 million, surpassing an all-day average of 681,000 Read More
from BAYSTREET RSS FEED
Possible Trend Reversal, United Therapeutics Down on Heavy Volume (UTHR)
March 25, 2013
from Comtex SmarTrend® News Briefs
United Therapeutics (UTHR) Falls after FDA Again Fails to Approve Oral Treprostinil NDA
March 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8208643 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
advertisement